Podcasts Will Be Featured On iTunes And Journal's Homepage
DIA today announced that Therapeutic Innovation & Regulatory Science (TIRS), its official peer-reviewed journal, will begin posting monthly podcasts. The podcasts will utilize a published article as the foundation and topic for discussion and will feature high-level thought leaders from industry, regulatory and academia. The first podcast is currently available and is posted on the journal’s homepage at http://dij.sagepub.com/. All subsequent discussions will be available on both the journal’s homepage and iTunes. This month’s feature is based on the special section Maternal and Child Health Therapeutics in the September 2013 issue of TIRS. In it, Editor-in-Chief Dr. Stephen Spielberg and Dr. Lode DeWulf discuss the urgent need for better data to guide clinical decision making during pregnancy.
We continue to seek new ways to ensure that TIRS grows and remains the foremost trusted resource for understanding and advancing the drug development industry and regulatory affairs,” said TIRS Editor-in-Chief, Dr. Stephen Spielberg. “This is in keeping with DIA’s mission to foster innovation across all pillars of industry. It is our intent to use technological advancements to move the needle of medical advancements. By finding new ways of disseminating essential information we will drive conversations that enable people worldwide to share knowledge and work together as never before.”
Issues of the new journal are available online at dij.sagepub.com/content/current
. For more information about DIA, Dr. Spielberg and TIRS
, visit www.diahome.org
ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.